Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Poland
  4. Warsaw Stock Exchange
  5. Mabion S.A.
  6. News
  7. Most relevant
    MAB   PLMBION00016

MABION S.A.

(MAB)
  Report
Delayed Warsaw Stock Exchange  -  05/19 11:55:44 am EDT
27.14 PLN   -0.77%
04/21Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Mabion S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
2021MABION S.A.(WSE : MAB) added to S&P Global BMI Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MABION S.A.
04/21Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Mabion S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
2021MABION S.A.(WSE : MAB) added to S&P Global BMI Index
CI
2021Mabion S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
2021Big pharma and private equity seek healthy returns in Europe's east
RE
2021MABION Announces Executive Changes
CI
2021Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2021Mabion S.A. Auditor Raises 'Going Concern' Doubt
CI
2021Polish Biotech Mabion Enters Deal To Manufacture Novavax COVID-19 Jab
MT
2021Mabion Biotech Signs Deal with Novavax on Covid-19 Vaccine Technology Transfer
CI
2020Mabion S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
2020Mabion S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
2020MABION S A : otrzyma do 15 mln zł pożyczek od akcjonariuszy na dalszy rozwój Spó..
PU
2020MABION S A : Zawarcie umów pożyczek od głównych akcjonariuszy Spółki
PU
2020Mabion S.A. announced that it expects to receive PLN 1.563755 million in funding
CI
2020Mabion S.A. Auditor Raises 'Going Concern' Doubt
CI
2019Mabion S.A. announced that it expects to receive €30 million in funding from European I..
CI
2017Mabion S.A. announced a financing transaction
CI
2016Mabion Signs Supply and Commercialization Agreement with Mylan Regarding Mabion CD20 fo..
CI
2015AMATHUS 3 FIZ fund of AMATHUS Towarzystwo Funduszy Inwestycyjnych S.A. acquired additio..
CI
2014Mabion Signs an Agreement with LYFIS ehf for Distribution of MabionCD20 in Iceland
CI
Analysis
Big pharma and private equity seek healthy returns in Europe's east
Upcoming sector events
07/27/22VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release (Projected)
07/27/22GILEAD SCIENCES, INC. : Interim 2022 Earnings Release (Projected)
08/04/22REGENERON PHARMACEUTICALS, INC. : Interim 2022 Earnings Release (Projected)
08/08/22BIONTECH SE : Interim 2022 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs